The efficacy of used engine oil against ticks on cattle

The study was conducted in a peri-urban agricultural system at Botshabelo, a city in the south-eastern Free State. A questionnaire survey revealed that 88.5% of cattle farmers in the area experienced problems related to ticks and tick-borne diseases. Because of the cost of commercial acaricides the Botshabelo farmers use alternative, cheaper methods of tick control, including the application of used engine oil. The specific aim of the study was to determine whether used engine oil can effectively control ticks on cattle. From March to August 1996 the tick burdens of ten control animals and six animals treated by their owner with used engine oil were compared. The total tick burdens for the 6 month period differed significantly between the two experimental groups. The efficacy of the used engine oil on the treated group varied between 15.1% and 64.8% with a mean of 38.1%. Although commercial acaricides can be more cost-effective, the application of used engine oil can be useful to reduce tick numbers on cattle during periods of peak abundance. Another advantage in that the use of the oil will not influence existing endemic stability of Anaplasma marginale and Babesia bigemina infections because of the residual tick burdens after treatment.     

Affinity of detomidine, medetomidine and xylazine for alpha-2 adrenergic receptor subtypes

α₂-Adrenergic receptor agonists are widely used in veterinary medicine as sedative/hypnotic agents. Four pharmacological subtypes of the α₂-adrenergic receptor (A, B, C and D) have been identified based primarily on differences in affinity for several drugs. The purpose of this study was to examine the affinities of the sedative agents, xylazine, detomidine and medetomidine at the four α₂-adrenergic receptor subtypes. Saturation and inhibition binding curves were performed in membranes of tissues containing only one subtype of a₂-adrenergic receptor. The K_D for the α₂-adrenergic receptor radioligand, [³H]-MK-912, in HT29 cells (α_2A-), neonatal rat lung (α_2B-), OK cells (α_2C-) and PC12 cells transfected with RG20 (α_2D-) were 0.38 ± 0.08 n m , 0.70 ± 0.5 n m , 0.07 ± 0.02 n m and 0.87 ± 0.03 n m , respectively. Detomidine and medetomidine had approximately a 100 fold higher affinity for all the α₂-adrenergic receptors compared to xylazine but neither agonist displayed selectivity for the α₂-adrenergic receptor subtypes. These data suggest that available sedative/hypnotic α₂-adrenergic receptor agonists can not discriminate between the four known α₂-adrenergic receptor subtypes.     

Leukocyte differentiation antigens in canine cutaneous and oral plasmacytomas

Seventeen cutaneous and oral tumours with light microscopic features of plasmacytomas from 16 dogs were studied. Clinically, most neoplasms were benign, although three recurred after excision and three were locally invasive. Tumours most often arose on the pinnae, digits, gingiva, and inguinal regions near areas of chronic inflammation and exhibited variable degrees of plasmacytic differentiation microscopically. Diagnosis of plasmacytoma was confirmed in paraffin-embedded tissues with a panel of leukocyte differentiation antigen markers that included cross-reactive antibodies for Mb-1 (CD79a), CD3, and vimentin and canine-specific antibodies for CD45RA and CD18. Immunoreactivity for Mb-1 and CD45RA, including staining of multinucleate cells and cells with karyomegaly, confirmed a B-cell origin of neoplasms, while staining for CD3 and CD18 revealed an extensive network of infiltrative T-cells and dendritic cells in tumours suggestive of a directed immune response. These findings (i) demonstrate the value of using a panel of antibodies for leukocyte antigens to differentiate plasmacytomas from other cutaneous and oral round cell tumours, and (ii) suggest that immune recognition and responsiveness within tumours may play a role in the behaviour of plasmacytomas in dogs by affecting tumour cell growth and differentiation.     

Clinical natural history of the postsurgical cruciate deficient canine stifle joint: year 1

The aims of this prospective study were to investigate the associations and correlations between individual clinical features of osteoarthritis of the cruciate deficient stifle joint and to document the temporal changes in these features over a 13-month period following surgical treatment. Fifty-eight dogs with osteoarthritis of the stifle joint, secondary to cranial cruciate ligament deficiency, were examined before surgical treatment for cruciate deficiency and at one and a half, seven and 13 months after surgery. At each visit, clinical features were graded using four-point, discontinuous, ordinal grading (Likert) scales and intra-articular pathology was also scored in a similar fashion at arthrotomy. No attempt was made to construct an aggregate score because the relative importance of different disease features and the relationships between them were not understood at the time of writing. At entry, the relationships between background and disease variables and clinical parameters were investigated as well as the relationships between clinical parameters and intra-articular pathology scores. Longitudinal analysis was performed to test for those features which showed significant change over the 13-month follow-up period. At entry, periarticular thickening and degree of crepitus were significantly correlated with disease duration. Several features showed significant change over the study period. Notably, the degree of quadriceps atrophy showed significant decrease from baseline scores at seven and 13 months while remaining different from normal, suggesting that a measure of quadriceps atrophy may be a useful measure of long-term outcome in this disease.     

A Combination Chemotherapy Protocol (VELCAP-L) for Dogs with Lymphoma

Ninety-eight dogs with lymphoma treated with a 5-drug combination chemotherapy regimen (vincristine, L-asparaginase. cyclophosphamide, doxorubicin, prednisone [VELCAP-L]) were evaluated for pretreatment characteristics predictive for response and remission duration. The complete remission rate was 69%, with a median remission duration of 55 weeks. Dogs with advanced stage of disease, constitutional signs, dogs that were older, and dogs that were dyspneic were less likely to achieve remission. Once in remission, small dogs and dogs without pretreatment thrombocytopenia were likely to have longer remission duration. Toxicoses were frequent, but rarely fatal, and no predictitive factors were found for a dog developing toxicoses. VELCAP-L is an effective treatment for dogs in stage I-III lymphoma, particularly in young, small animals.     

Isolation of Mycobacterium species from raw milk of pastoral cattle of the Southern Highlands of Tanzania

A study to determine the secretion of Mycobacterium spp. in milk from indigenous cattle was carried out in pastoral cattle reared in the Southern Highlands of Tanzania. The study was aimed at elucidating the dangers associated with milk-borne zoonoses in a society where milk is normally consumed raw. Out of 805 milk samples, 31 (3.9%) were positive for mycobacteria. There was a preponderance of atypical mycobacteria (87%) whereas only two isolates (6.5%) were confirmed as M. bovis. Atypical mycobacteria included: M. terrae (n=7), M. fortuitum (n=2), M. flavescens (n=13), M. gordonae (n=1) and M. smegmatis (n=4). Although the number of M. bovis positive samples was low, the habit of pooling milk may still pose great public health dangers to milk consumers in this part of the world. Moreover, isolation of atypical mycobacteria should also be considered to be a danger to human health in countries such as Tanzania, where the number of people with lowered immunity due to HIV infection is on the increase.